An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions

Keyphrases

• Airway 12%
• Antibody Technology 12%
• Bacterial Pathogens 12%
• Functional Activity 12%
• Glycosylation Profile 12%
• Immunoglobulin 100%
• In Vitro Activity 12%
• J Chain 12%
• Life-threatening 12%
• Lipid Nanoparticles 12%
• Lung 12%
• Monoclonal Antibody 12%
• MRNA Lipid Nanoparticle 12%
• Mucosal Secretion 100%
• Mucosal Surfaces 12%
• Pathogen-specific 100%
• Pathogenic Bacteria 12%
• Peyer's Patches 12%
• Prophylactic Treatment 12%
• Pseudomonas 12%
• Salmonella 12%
• Serum Half-life 12%
• Specific Immunoglobulins 100%
• Synthetic mRNA 12%
• Systemic Infection 12%
• Therapeutic Intervention 12%
• Tissue Destruction 12%

Medicine and Dentistry

• Glycosylation 12%
• Gut 12%
• Immunoglobulin A 100%
• In Vitro 12%
• Lung 12%
• Messenger RNA 100%
• Monoclonal Antibody 12%
• Mucosal Surface 12%
• Nanoparticle 25%
• Pathogen 100%
• Peyer's Patch 12%
• Plasma Half Life 12%
• Pseudomonas 12%
• Salmonella 12%
• Secretion (Process) 100%
• Sepsis 12%

Immunology and Microbiology

• Glycosylation 12%
• Immunoglobulin A 100%
• Immunology 12%
• Infectious Agent 100%
• J Chain 12%
• Monoclonal Antibody 12%
• Peyer's Patch 12%
• Plasma Half Life 12%
• Pseudomonas 12%
• Salmonella 12%
• Secretion (Process) 100%